Search company, investor...


Unattributed | Alive

Total Raised


Last Raised

$80K | 13 yrs ago

About ThermalTherapeutic Systems

ThermalTherapeutic Systems is currently developing a portable next-generation perfusion device for international distribution.

Headquarters Location

Pittsburgh, Pennsylvania, 15219,

United States



Latest ThermalTherapeutic Systems News

ThermalTherapeutic raising funds to commercialize perfusion device

Nov 15, 2011

Share / Nov 15, 2011 at 2:43 PM ThermalTherapeutic Systems has raised $800,000 toward a round of investment that will fund the commercial launch of its hyperthermic perfusion device. The portable device, called the VeraTherm , received U.S. Food and Drug Administration clearance in March 2010. The 26-pound device is used to pump heated or unheated fluid into patients’ abdomens or chest cavities. Hyperthermic perfusion is sometimes used in treating cancer. The procedure involves a warmed solution containing anticancer drugs that is used to bathe, or is passed through the blood vessels of, the tissue or organ containing a tumor. Newly hired CEO Gardiner Smith said the Pittsburgh-based company is in the midst of raising a series B round to fund commercialization of the device. A document filed with the U.S. Securities and Exchange Commission said the company was targeting $2 million for the round, but Smith said the amount of equity funding the company raises will likely depend on how well the device sells. Advertisement The latest funding comes from existing investors, including Bethlehem, Pennsylvania-based Originate Ventures , which led the company’s $2.75 million series A round in 2009, Smith said. ThermalTherapeutic is also looking to begin selling the device in international markets, according to Smith. “The hyperthermic perfusion market is one where the unmet medical need is high, and we believe it’s a largely untapped market,” Smith said.  

ThermalTherapeutic Systems Frequently Asked Questions (FAQ)

  • Where is ThermalTherapeutic Systems's headquarters?

    ThermalTherapeutic Systems's headquarters is located at Pittsburgh.

  • What is ThermalTherapeutic Systems's latest funding round?

    ThermalTherapeutic Systems's latest funding round is Unattributed.

  • How much did ThermalTherapeutic Systems raise?

    ThermalTherapeutic Systems raised a total of $3.03M.

  • Who are the investors of ThermalTherapeutic Systems?

    Investors of ThermalTherapeutic Systems include Pittsburgh Life Sciences Greenhouse, Innovation Works and Originate Ventures.

  • Who are ThermalTherapeutic Systems's competitors?

    Competitors of ThermalTherapeutic Systems include ALung Technologies, ADVOS, DFine, Penumbra, Hotspur Technologies and 7 more.


Compare ThermalTherapeutic Systems to Competitors

Acorn Cardiovascular

Acorn Cardiovascular is a medical device company pursuing treatments for patients with heart failure. Acorn


Antivirals is engaged in the discovery of agents that inhibit replication of human pathogenic viruses.


ADVOS, developed by ADVITOS, is a company focused on the healthcare sector, specifically in the field of intensive care treatment. The company's main offering is a certified innovative treatment for multi-organ failure in intensive care units, which simultaneously supports the kidney, liver, and lung functions, and also regulates the pH of the blood. The primary customers of ADVOS are likely to be healthcare providers in the intensive care industry. ADVOS was formerly known as Hepa Wash. It was founded in 2004 and is based in Munich, Germany.

Fairway Medical Technologies

Fairway Medical Technologies is an FDA registered medical device, design, development and manufacturing company. It invents, innovates, and invests in medical technologies. In addition to supporting early stage startups with technology and business development, Fairway helps them obtain SBIR (Small Business Innovative Research) and other commercialization grants. As of 2009, Fairway and its Portfolio Companies have received over $15 Million in grants from the National Institute of Health (NIH) and the State of Texas' Emerging Technology Fund (ETF).

Salutaris Medical Devices

Salutaris Medical Devices is a clinical stage medical device company focused on the ophthalmic sector. The company's main product is a patented, FDA-cleared device called BetaCurve, designed to treat various eye diseases, including advanced age-related macular degeneration, using precision beta radiotherapy. The device is used in a quick, outpatient procedure that requires only one treatment, offering a potential alternative for patients who do not respond well to standard treatments. It is based in Tucson, Arizona.

Carticept Medical

Carticept Medical is a medical device-developing company. It provides solutions for patients with osteoarthritis and cartilage damage. It offers products to address the shortcomings of the current conservative and surgical treatment options for osteoarthritis and cartilage injuries such as ultrasound products, computer-controlled infusion systems, and a medical device to replace and repair worn and damaged cartilage. Carticept Medical was formerly known as Windward Medical. The company was founded in 2005 and is based in Alpharetta, Georgia.


CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.